SRPT Sarepta Therapeutics, Inc.
Nasdaq · SEC CIK 873303 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $417.4K 2 sales by 2 insiders
- Filings on record
- 179 since 2021-09-09, latest 2026-09-08 20:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Estepan Ian Michael | COO | — | $294.2K |
| Mayo Stephen | Dir | — | $123.2K |
| Wong Ryan Ho-Yan | CFO | — | — |
| Rothfuss Cristin | EVP, GC | — | — |
| Chambers Michael Andrew | Dir | — | — |
| Rodino-Klapac Louise | Pres, R, D, Tech Ops | — | — |
| Boor Kathryn Jean | Dir | — | — |
| Nicaise Claude | Dir | — | — |
| SEVERINO MICHAEL | CEO, Dir | — | — |
| Barry Richard | Dir | — | — |
Transactions 210
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-03-01 | SRPT | Brown Ryan Edward | SVP, GC | F - Tax | $75.05 | -184 | 19.2K | -1.0% | -$13.8K | |
| 2022-03-01 | 2022-03-01 | SRPT | Estepan Ian Michael | CFO | F - Tax | $75.05 | -376 | 26.4K | -1% | -$28.2K | |
| 2022-03-01 | 2022-03-01 | SRPT | Rodino-Klapac Louise | CSO, Head of R, D | F - Tax | $75.05 | -572 | 65.3K | -0.9% | -$42.9K | |
| D | 2021-12-16 | 2021-12-15 | SRPT | BEHRENS M KATHLEEN | Dir | M - OptEx | $10.08 | +5,000 | 135.5K | +4% | +$50.4K |
| D | 2021-12-14 | 2021-12-10 | SRPT | GRAY MARY ANN | Dir | M - OptEx | $0.00 | +967 | 9,403 | +11% | $0 |
| 2021-11-29 | 2021-11-24 | SRPT | Rodino-Klapac Louise | CSO, Head of R, D | P - Purchase | $79.33 | +3,780 | 65.7K | +6% | +$299.9K | |
| 2021-11-17 | 2021-11-16 | SRPT | Rodino-Klapac Louise | CSO | A - Grant | $0.00 | +40.0K | 61.9K | +183% | $0 | |
| D | 2021-11-17 | 2021-11-16 | SRPT | Mayo Stephen | Dir | A - Grant | $0.00 | +4,292 | 4,292 | New | $0 |
| 2021-11-17 | 2021-11-17 | SRPT | INGRAM DOUGLAS S | Pres, CEO, Dir | P - Purchase | $79.94 | +25.0K | 365.1K | +7% | +$2.00M | |
| 2021-09-09 | 2021-09-08 | SRPT | Estepan Ian Michael | CFO | F - Tax | $78.29 | -1,623 | 26.8K | -6% | -$127.1K |
Purchase Sale Sale after option exercise All abbreviations